Jingcao Huang

1.3k total citations
51 papers, 907 citations indexed

About

Jingcao Huang is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Jingcao Huang has authored 51 papers receiving a total of 907 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 23 papers in Hematology and 19 papers in Oncology. Recurrent topics in Jingcao Huang's work include Multiple Myeloma Research and Treatments (14 papers), Protein Degradation and Inhibitors (9 papers) and Peptidase Inhibition and Analysis (7 papers). Jingcao Huang is often cited by papers focused on Multiple Myeloma Research and Treatments (14 papers), Protein Degradation and Inhibitors (9 papers) and Peptidase Inhibition and Analysis (7 papers). Jingcao Huang collaborates with scholars based in China, United States and South Korea. Jingcao Huang's co-authors include Bolin Liu, Hui Lyu, Jian Ma, Jianxiang Wang, Shuiliang Wang, Yuhuan Zheng, Zhimin He, Bo Cai, Hong Wu and Fangfang Wang and has published in prestigious journals such as Advanced Materials, Clinical Cancer Research and Journal of Bone and Mineral Research.

In The Last Decade

Jingcao Huang

47 papers receiving 897 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jingcao Huang China 16 515 369 180 128 126 51 907
Antreas Hindoyan United States 11 409 0.8× 365 1.0× 128 0.7× 48 0.4× 125 1.0× 24 767
Thomas Kryza Australia 16 256 0.5× 268 0.7× 160 0.9× 69 0.5× 48 0.4× 33 657
Robert McKinstry United States 13 475 0.9× 435 1.2× 98 0.5× 50 0.4× 145 1.2× 21 971
Cristina Nieto‐Jiménez Spain 16 456 0.9× 464 1.3× 137 0.8× 56 0.4× 84 0.7× 40 942
N. Gabrail United States 14 288 0.6× 569 1.5× 309 1.7× 64 0.5× 57 0.5× 32 924
Iñigo Martínez-Zubiaurre Norway 20 371 0.7× 579 1.6× 269 1.5× 137 1.1× 37 0.3× 33 1.1k
Dan Georgess United States 11 427 0.8× 260 0.7× 91 0.5× 146 1.1× 44 0.3× 16 1.0k
Ivan Ischenko Germany 19 621 1.2× 507 1.4× 269 1.5× 44 0.3× 44 0.3× 22 1.2k
Hillary J. Millar United States 9 483 0.9× 356 1.0× 150 0.8× 84 0.7× 61 0.5× 14 773
Carolina Zandueta Spain 17 443 0.9× 305 0.8× 281 1.6× 49 0.4× 49 0.4× 25 833

Countries citing papers authored by Jingcao Huang

Since Specialization
Citations

This map shows the geographic impact of Jingcao Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingcao Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingcao Huang more than expected).

Fields of papers citing papers by Jingcao Huang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jingcao Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingcao Huang. The network helps show where Jingcao Huang may publish in the future.

Co-authorship network of co-authors of Jingcao Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Jingcao Huang. A scholar is included among the top collaborators of Jingcao Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingcao Huang. Jingcao Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Qing, Fangfang Wang, Леи Жао, et al.. (2025). Chidamide and cytarabine synergistically treat acute myeloid leukemia: inhibiting ribosome biogenesis via the MYC-RRP9 pathway. Cell Death and Disease. 16(1). 601–601.
2.
Yang, Yan, et al.. (2025). Visual Detection on Aircraft Wing Icing Process Using a Lightweight Deep Learning Model. Aerospace. 12(7). 627–627.
3.
Liu, Xiang, Song Liu, Jingcao Huang, et al.. (2025). The mitochondrial protease ClpP is a promising target for multiple myeloma treatment. Biochemical Pharmacology. 236. 116855–116855. 1 indexed citations
4.
Wen, Jingjing, Linfeng Li, Xiaohui Zhao, et al.. (2025). Beneficial effects of aerobic exercises on multiple myeloma: Mechanisms and clinical observations. International Journal of Cancer. 157(11). 2343–2353.
5.
Luo, Hongmei, Feng Yu, Fangfang Wang, et al.. (2023). Combinations of ivermectin with proteasome inhibitors induce synergistic lethality in multiple myeloma. Cancer Letters. 565. 216218–216218. 7 indexed citations
6.
Feng, Yu, Jingcao Huang, Fangfang Wang, et al.. (2023). Methylcrotonyl-CoA carboxylase subunit 1 (MCCA) regulates multidrug resistance in multiple myeloma. Life Sciences. 333. 122157–122157. 3 indexed citations
7.
Huang, Jingcao, et al.. (2022). Fault diagnosis of hydropower generator based on LSTM- weight. 369–373. 1 indexed citations
8.
Gao, Yuhan, Jingcao Huang, Zhuang Yang, et al.. (2022). ISG20L2 suppresses bortezomib antimyeloma activity by attenuating bortezomib binding to PSMB5. JCI Insight. 7(19). 6 indexed citations
9.
Luo, Hongmei, Yuhuan Zheng, Jingcao Huang, et al.. (2020). <p>PIM3 Promotes the Proliferation and Migration of Acute Myeloid Leukemia Cells</p>. OncoTargets and Therapy. Volume 13. 6897–6905. 11 indexed citations
10.
Li, Qing, et al.. (2020). Chidamide plus decitabine synergistically induces apoptosis of acute myeloid leukemia cells by upregulating PERP.. PubMed. 12(7). 3461–3475. 5 indexed citations
11.
12.
13.
14.
Zhao, Pan, Jingcao Huang, Dan Zhang, et al.. (2018). SLC2A5 overexpression in childhood philadelphia chromosome‐positive acute lymphoblastic leukaemia. British Journal of Haematology. 183(2). 242–250. 13 indexed citations
15.
Chen, Qiang, Fangfang Wang, Qiuyang Li, et al.. (2018). Hypoxia with Wharton’s jelly mesenchymal stem cell coculture maintains stemness of umbilical cord blood-derived CD34+ cells. Stem Cell Research & Therapy. 9(1). 158–158. 34 indexed citations
16.
Lyu, Hui, Jingcao Huang, Susan M. Edgerton, et al.. (2015). Increased erbB3 promotes erbB2/neu-driven mammary tumor proliferation and co-targeting of erbB2/erbB3 receptors exhibits potent inhibitory effects on breast cancer cells.. PubMed. 8(6). 6143–56. 10 indexed citations
17.
Mo, Wei, et al.. (2014). Pre-release sales forecasting: A model-driven context feature extraction approach. IBM Journal of Research and Development. 58(5/6). 8:1–8:13. 2 indexed citations
18.
Wang, Shuiliang, Jingcao Huang, Hui Lyu, et al.. (2013). Therapeutic targeting of erbB3 with MM-121/SAR256212 enhances antitumor activity of paclitaxel against erbB2-overexpressing breast cancer. Breast Cancer Research. 15(5). R101–R101. 42 indexed citations
19.
Huang, Jingcao, Shuiliang Wang, Hui Lyu, et al.. (2013). The anti-erbB3 antibody MM-121/SAR256212 in combination with trastuzumab exerts potent antitumor activity against trastuzumab-resistant breast cancer cells. Molecular Cancer. 12(1). 134–134. 54 indexed citations
20.
Tsai, Yao-Yang, et al.. (2010). Real Time Depth Sensing with Automatic Determined Depth Range for Human Computer Interactive Applications.. IPCV. 457–461. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Antreas Hindoyan Breakdown of academic impact, for papers by Thomas Kryza Breakdown of academic impact, for papers by Robert McKinstry Breakdown of academic impact, for papers by Cristina Nieto‐Jiménez Breakdown of academic impact, for papers by N. Gabrail Breakdown of academic impact, for papers by Iñigo Martínez-Zubiaurre Breakdown of academic impact, for papers by Dan Georgess Breakdown of academic impact, for papers by Ivan Ischenko Breakdown of academic impact, for papers by Hillary J. Millar Breakdown of academic impact, for papers by Carolina Zandueta
Rankless by CCL
2026